Ryght AI to Showcase AI-Powered Clinical Research Solutions at HLTH 2025
LAGUNA BEACH, Calif. - Ryght AI, a pioneering platform that enhances clinical trial execution through advanced AI Site Twin technology, has announced its presence as a featured partner at the Microsoft Booth (#3860, Level 2, AI Zone) during the upcoming HLTH 2025 conference in Las Vegas, scheduled for October 19-22. This premier health innovation event is expected to attract over 12,000 industry leaders, sponsors, and Contract Research Organizations (CROs) looking to engage with cutting-edge technology in healthcare.
During the conference, attendees will have the chance to witness live demonstrations of Ryght's innovative generative AI platform. This technology promises a transformation in how clinical trials are conducted, focusing on aspects such as site selection, feasibility, and overall study operations. Ryght AI's strategic collaboration with Microsoft and its recent integration into the Microsoft Azure Marketplace signifies a significant shift toward AI-driven solutions within clinical research.
"HLTH presents an invaluable opportunity to connect with healthcare innovators who are eager for solutions designed to expedite clinical trial timelines," stated Simon Arkell, CEO and Co-Founder of Ryght AI. "Our collaboration with Microsoft has opened new pathways for sponsors and CROs looking to utilize their existing cloud investments to adopt state-of-the-art AI technologies. We are thrilled to showcase how our platform, built on AI Site Twin technology, aids organizations in delivering treatments to patients more swiftly while reducing costs and operational complexities."
What are AI Site Twins?
Ryght AI's core innovation revolves around AI Site Twins—dynamic digital representations of clinical research sites worldwide. Each AI Site Twin encapsulates essential information about the operational characteristics, historical performance in trials, Principal Investigator (PI) expertise, and regulatory history of individual research sites. This digital model allows sponsors and CROs to streamline traditionally manual processes, yielding substantial reductions in trial startup times, sometimes by as much as 60%. By reducing the time spent on site identification and feasibility workflows, Ryght AI accelerates the journey of new treatments to market, translating saved time into significant economic advantages for organizations, including extended market exclusivity.
Key Features of Ryght AI's Platform
Ryght's platform enhances clinical research operations across several key performance indicators:
- - Reduced Delays: Intelligent automation speeds up site startup, ensuring a more efficient process.
- - Enhanced Accuracy: Improved enrollment forecasting and budget modeling minimize financial risks associated with trials.
- - Cost Optimization: Better upfront planning helps decrease the chances of mid-trial delays, unexpected costs, and amendments.
- - Improved Efficiency: Direct communication with high-capacity research partners streamlines site engagement, enhancing operational workflow.
Interested participants can visit Ryght at Microsoft Booth #3860 in the AI Zone throughout the conference for personalized demonstrations. Those looking to schedule a demonstration in advance are encouraged to visit
Ryght's HLTH 2025 page. Ryght's integration into the Microsoft Azure Marketplace enables healthcare organizations to tap into existing Azure cloud commitments, enhancing their operational capabilities with advanced AI tools.
The Future of Clinical Trials
Ryght AI, with its focus on pioneering AI Site Twin technology, is revolutionizing clinical trial timelines. This intelligent platform not only accelerates clinical trial initiation through faster site selection and efficient feasibility processes but also establishes seamless, real-time communication among sponsors, CROs, and research sites, leading to enhanced operational efficiency.
For further details or to arrange a personalized demo at HLTH 2025, please visit
Ryght's website or stop by Microsoft Booth #3860 at the conference. The future of clinical trials is being reshaped by Ryght AI, and this conference serves as a unique platform to witness these advancements firsthand.